Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4

1(33.3%)

Phase 3

1(33.3%)

N/A

1(33.3%)

3Total

Phase 4(1)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04189575Not ApplicableUnknown

A Text Messaging (SMS) Intervention to Improve Adherence to Stimulant Medication in Adults With ADHD in the Primary Care Setting

Role: collaborator

NCT00413595Completed

Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation

Role: collaborator

NCT00414583Completed

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients

Role: collaborator

NCT01412372Phase 3Completed

The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study

Role: collaborator

NCT01873911Completed

Neurobehavioral Phenotypes in MPS III

Role: collaborator

NCT01457430Phase 4Completed

Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE

Role: collaborator

All 6 trials loaded